Axon degeneration is key component of neuronal death in amyloid-β toxicity

被引:35
作者
Alobuia, Wilson M. [1 ]
Xia, Wei [1 ]
Vohra, Bhupinder P. S. [1 ]
机构
[1] Univ Cent Arkansas, Dept Biol, Conway, AR 72035 USA
基金
美国国家卫生研究院;
关键词
Amyloid-beta; Nmnat; Axon degeneration; Bcl-xl; Alzheimer's; PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; BCL-2; ACTIVATION; PEPTIDE; CELLS; APP; A-BETA(1-42); PROGRESSION; A-BETA-42;
D O I
10.1016/j.neuint.2013.08.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Depending upon the stimulus, neuronal cell death can either be triggered from the cell body (soma) or the axon. We investigated the origin of the degeneration signal in amyloid beta (A beta) induced neuronal cell death in cultured in vitro hippocampal neurons. We discovered that A beta(1-42) toxicity-induced axon degeneration precedes cell death in hippocampal neurons. Overexpression of Bcl-xl inhibited both axonal and cell body degeneration in the A beta-42 treated neurons. Nicotinamide mononucleotide adenylyltransferase 1 (Nmnat1) blocks axon degeneration in a variety of paradigms, but it cannot block neuronal cell body death. Therefore, if the neuronal death signals in A beta(1-42) toxicity originate from degenerating axons, we should be able to block neuronal death by inhibiting axon degeneration. To explore this possibility we over-expressed Nmnat1 in hippocampal neurons. We found that inhibition of axon degeneration in A beta(1-42) treated neurons prevented neuronal cell death. Thus, we conclude that axon degeneration is the key component of A beta(1-42) induced neuronal degeneration, and therapies targeting axonal protection can be important in finding a treatment for Alzheimer's disease. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:782 / 789
页数:8
相关论文
共 47 条
[1]   Caspase-6 Activation in Familial Alzheimer Disease Brains Carrying Amyloid Precursor Protein or Presenilin I or Presenilin II Mutations [J].
Albrecht, Steffen ;
Bogdanovic, Nenad ;
Ghetti, Bernardino ;
Winblad, Bengt ;
LeBlanc, Andrea C. .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (12) :1282-1293
[2]   Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration [J].
Araki, T ;
Sasaki, Y ;
Milbrandt, J .
SCIENCE, 2004, 305 (5686) :1010-1013
[3]   The WldS gene delays axonal but not somatic degeneration in a rat glaucoma model [J].
Beirowski, Bogdan ;
Babetto, Elisabetta ;
Coleman, Michael P. ;
Martin, Keith R. .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2008, 28 (06) :1166-1179
[4]  
Burke R.E., 2012, EXP NEUROL
[5]   Oxidative Stress and β-Amyloid Protein in Alzheimer's Disease [J].
Cai, Zhiyou ;
Zhao, Bin ;
Ratka, Anna .
NEUROMOLECULAR MEDICINE, 2011, 13 (04) :223-250
[6]   Aβ Toxicity in Alzheimer's Disease [J].
Cavallucci, Virve ;
D'Amelio, Marcello ;
Cecconi, Francesco .
MOLECULAR NEUROBIOLOGY, 2012, 45 (02) :366-378
[7]   Aβ1-42 induces mild endoplasmic reticulum stress in an aggregation state-dependent manner [J].
Chafekar, Sidhartha M. ;
Hoozemans, Jeroen J. M. ;
Zwart, Rob ;
Baas, Frank ;
Scheper, Wiep .
ANTIOXIDANTS & REDOX SIGNALING, 2007, 9 (12) :2245-2254
[8]   Clinical Progression in Parkinson Disease and the Neurobiology of Axons [J].
Cheng, Hsiao-Chun ;
Ulane, Christina M. ;
Burke, Robert E. .
ANNALS OF NEUROLOGY, 2010, 67 (06) :715-725
[9]   Self-assembly of Aβ1-42 into globular neurotoxins [J].
Chromy, BA ;
Nowak, RJ ;
Lambert, MP ;
Viola, KL ;
Chang, L ;
Velasco, PT ;
Jones, BW ;
Fernandez, SJ ;
Lacor, PN ;
Horowitz, P ;
Finch, CE ;
Krafft, GA ;
Klein, WL .
BIOCHEMISTRY, 2003, 42 (44) :12749-12760
[10]   Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability [J].
Dahlgren, KN ;
Manelli, AM ;
Stine, WB ;
Baker, LK ;
Krafft, GA ;
LaDu, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (35) :32046-32053